Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)-Reference-Cited by-同舟云学术

Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)

Published:2018-09 Issue: Volume:72 Page:92-95
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Zeidner Joshua F.^ORCID,Foster Matthew C.,Blackford Amanda L.,Litzow Mark R.,Morris Lawrence E.,Strickland Stephen A.^ORCID,Lancet Jeffrey E.,Bose Prithviraj,Levy M. Yair,Tibes Raoul,Gojo Ivana,Gocke Christopher D.,Rosner Gary L.,Little Richard F.,Wright John J.,Doyle L. Austin,Smith B. Douglas,Karp Judith E.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial;Karp;Clin. Cancer Res.,2003

2. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias;Karp;Clin. Cancer Res.,2005

3. Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia;Karp;Clin. Cancer Res.,2007

4. Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia;Karp;Leuk. Res.,2010

5. Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias;Karp;Blood,2011

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transformation routes of tetrafluoroflavones in the reactions with aliphatic amines;Russian Chemical Bulletin;2024-06

2. Antioxidants activities of phytochemicals perspective modulation of autophagy and apoptosis to treating cancer;Biomedicine & Pharmacotherapy;2024-05

3. Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution;Blood Reviews;2023-11

4. Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic way;Phytochemistry Reviews;2023-10-11

5. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response;Nature Communications;2023-08-18